🚀 VC round data is live in beta, check it out!
CollPlant Valuation Multiples
Discover revenue and EBITDA valuation multiples for CollPlant and similar public comparables like PolarCool, Vicarious Surgical, Co-Diagnostics, Redsense Medical and more.
CollPlant Overview
About CollPlant
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Founded
1981
HQ
Employees
57
Website
Financials (LTM)
EV
$2M
CollPlant Financials
CollPlant reported last 12-month revenue of $2M.
In the same LTM period, CollPlant generated $1M in gross profit and had net loss of ($12M).
Revenue (LTM)
CollPlant P&L
In the most recent fiscal year, CollPlant reported revenue of $2M and EBITDA of ($11M).
CollPlant expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2M | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | $1M | XXX | $2M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 65% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($11M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (446%) | XXX | XXX | XXX |
| EBIT Margin | (516%) | XXX | (484%) | XXX | XXX | XXX |
| Net Profit | ($12M) | XXX | ($11M) | XXX | XXX | XXX |
| Net Margin | (516%) | XXX | (485%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
CollPlant Stock Performance
CollPlant has current market cap of $5M, and enterprise value of $2M.
Market Cap Evolution
CollPlant's stock price is $0.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2M | $5M | 9.0% | XXX | XXX | XXX | $-0.80 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCollPlant Valuation Multiples
CollPlant trades at 0.8x EV/Revenue multiple, and (0.2x) EV/EBITDA.
EV / Revenue (LTM)
CollPlant Financial Valuation Multiples
As of April 16, 2026, CollPlant has market cap of $5M and EV of $2M.
Equity research analysts estimate CollPlant's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CollPlant has a P/E ratio of (0.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV (current) | $2M | XXX | $2M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.2x) | XXX | XXX | XXX |
| EV/EBIT | (0.2x) | XXX | (0.2x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.4x | XXX | 1.2x | XXX | XXX | XXX |
| P/E | (0.4x) | XXX | (0.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (0.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified CollPlant Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
CollPlant Margins & Growth Rates
CollPlant's revenue in the last 12 month declined by (5%).
CollPlant's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
CollPlant Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (5%) | XXX | (16%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (446%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (35%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 214% | XXX | 204% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 363% | XXX | 345% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 549% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
CollPlant Public Comps
See public comps and valuation multiples for other Medical Devices and 3D Printing comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| CollPlant | XXX | XXX | XXX | XXX | XXX | XXX |
| PolarCool | XXX | XXX | XXX | XXX | XXX | XXX |
| Vicarious Surgical | XXX | XXX | XXX | XXX | XXX | XXX |
| Co-Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Redsense Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Zenicor Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CollPlant M&A Activity
CollPlant acquired XXX companies to date.
Last acquisition by CollPlant was on XXXXXXXX, XXXXX. CollPlant acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by CollPlant
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCollPlant Investment Activity
CollPlant invested in XXX companies to date.
CollPlant made its latest investment on XXXXXXXX, XXXXX. CollPlant invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by CollPlant
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout CollPlant
| When was CollPlant founded? | CollPlant was founded in 1981. |
| Where is CollPlant headquartered? | CollPlant is headquartered in United States. |
| How many employees does CollPlant have? | As of today, CollPlant has over 57 employees. |
| Who is the CEO of CollPlant? | CollPlant's CEO is Eran Rotem. |
| Is CollPlant publicly listed? | Yes, CollPlant is a public company listed on Nasdaq. |
| What is the stock symbol of CollPlant? | CollPlant trades under CLGN ticker. |
| When did CollPlant go public? | CollPlant went public in 2021. |
| Who are competitors of CollPlant? | CollPlant main competitors are PolarCool, Vicarious Surgical, Co-Diagnostics, Redsense Medical. |
| What is the current market cap of CollPlant? | CollPlant's current market cap is $5M. |
| What is the current revenue of CollPlant? | CollPlant's last 12 months revenue is $2M. |
| What is the current revenue growth of CollPlant? | CollPlant revenue growth (NTM/LTM) is (5%). |
| What is the current EV/Revenue multiple of CollPlant? | Current revenue multiple of CollPlant is 0.8x. |
| Is CollPlant profitable? | No, CollPlant is not profitable. |
| What is the current net income of CollPlant? | CollPlant's last 12 months net income is ($12M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.